Twist Bioscience Balance Sheet Health
Financial Health criteria checks 5/6
Twist Bioscience has a total shareholder equity of $472.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $614.3M and $141.6M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$276.40m |
| Equity | US$472.69m |
| Total liabilities | US$141.63m |
| Total assets | US$614.32m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0ME's short term assets ($346.8M) exceed its short term liabilities ($71.0M).
Long Term Liabilities: 0ME's short term assets ($346.8M) exceed its long term liabilities ($70.6M).
Debt to Equity History and Analysis
Debt Level: 0ME is debt free.
Reducing Debt: 0ME has no debt compared to 5 years ago when its debt to equity ratio was 5.1%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0ME has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 0ME has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.